Bioadaptives (BDPT) Operating Margin (2019 - 2025)
Historic Operating Margin for Bioadaptives (BDPT) over the last 7 years, with Q3 2025 value amounting to 5735.95%.
- Bioadaptives' Operating Margin changed N/A to 5735.95% in Q3 2025 from the same period last year, while for Sep 2025 it was 14410.84%, marking a year-over-year decrease of 127674800.0%. This contributed to the annual value of 4752.47% for FY2024, which is 39510600.0% down from last year.
- According to the latest figures from Q3 2025, Bioadaptives' Operating Margin is 5735.95%.
- Bioadaptives' Operating Margin's 5-year high stood at 415.47% during Q1 2024, with a 5-year trough of 13774.52% in Q2 2024.
- Its 5-year average for Operating Margin is 3514.14%, with a median of 2770.7% in 2022.
- Per our database at Business Quant, Bioadaptives' Operating Margin crashed by -113825100bps in 2024 and then soared by 51004300bps in 2025.
- Over the past 5 years, Bioadaptives' Operating Margin (Quarter) stood at 4615.27% in 2021, then soared by 85bps to 685.29% in 2022, then fell by -25bps to 857.99% in 2023, then plummeted by -1505bps to 13774.52% in 2024, then surged by 58bps to 5735.95% in 2025.
- Its Operating Margin stands at 5735.95% for Q3 2025, versus 8674.09% for Q2 2025 and 13774.52% for Q2 2024.